Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc Stock

69.69P/E
€13.83BMarket capitalisation
US$3.38Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals Plc is registered in the following country: Ireland (Exchange: USNASD).

Key metrics

Key metrics and master data for the Jazz Pharmaceuticals Plc stock.

Market capitalisation
€13.83B
P/E
69.69
P/B
3.53
P/S
3.33
P/CF
9.09
Issued shares 64M Units

Return

Here you can see the performance of the Jazz Pharmaceuticals Plc stock.

PeriodPerfor­mance
1 Week-4.97 %
1 Month+13.47 %
3 Months-3.36 %
6 Months+38.44 %
1 Year+110.67 %
YTD+38.97 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Jazz Pharmaceuticals Plc share.

DateRatio
No data available.

Which ETF contains the Jazz Pharmaceuticals Plc stock?

The Jazz Pharmaceuticals Plc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Jazz Pharmaceuticals Plc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Jazz Pharmaceuticals Plc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.